Vis enkel innførsel

dc.contributor.authorOutterson, Kevin
dc.contributor.authorGopinathan, Unni
dc.contributor.authorClift, Charles
dc.contributor.authorSo, Anthony D.
dc.contributor.authorMorel, Chantal M.
dc.contributor.authorRøttingen, John-Arne
dc.date.accessioned2017-03-02T11:50:46Z
dc.date.available2017-03-02T11:50:46Z
dc.date.created2016-11-01T14:18:16Z
dc.date.issued2016
dc.identifier.citationNature Methods. 2016, 13 (6), .
dc.identifier.issn1548-7091
dc.identifier.urihttp://hdl.handle.net/11250/2432717
dc.language.isoeng
dc.relation.urihttp://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002043&type=printable
dc.titleDelinking investment in antibiotic research and development from sales revenues: the challenges of transforming a promising idea into reality
dc.typePeer reviewed
dc.typeJournal article
dc.source.pagenumber7
dc.source.volume13
dc.source.journalNature Methods
dc.source.issue6
dc.identifier.doi10.1371/journal.pmed.1002043
dc.identifier.cristin1396271
cristin.unitcode7502,4,21,0
cristin.unitcode7502,2,0,0
cristin.unitnameInternasjonal folkehelse
cristin.unitnameInstituttledelse
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel